Bone Biologics financials at a glance
| Year | Year | 2016 | 2017 | 2018 | 2019 | 2015 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-84.00 | $-31.20 | $-3.23 | $0.00 | ||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
3.88m | 3.91m | 8.32m | 30.68m | 0m | 0.05m | 0.04m | 0.06m | 0m | 0.88m |
| OCF | Operating Cash Flow |
|
$-7.33M | $-3.33M | $-4.10M | $-3.25M | $-3.55M | $-0.43M | $-1.23M | $-3.57M | $-9.56M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-1.95 | $-0.86 | $-0.82 | $-0.11 | $-1.25 | $-0.03 | $-0.12 | $-74.94 | $-36.32 | $0.00 |